Eric P. Lefkofsky Sells 562,345 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 562,345 shares of the business’s stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $50.93, for a total transaction of $28,640,230.85. Following the completion of the transaction, the chief executive officer now directly owns 9,457,283 shares in the company, valued at $481,659,423.19. This trade represents a 5.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Tempus AI Trading Up 0.5 %

Shares of NASDAQ TEM opened at $49.10 on Monday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The business has a 50-day simple moving average of $54.30 and a two-hundred day simple moving average of $52.30.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on TEM shares. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their target price for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Needham & Company LLC upped their price objective on Tempus AI from $56.00 to $70.00 and gave the company a “buy” rating in a research note on Tuesday, February 25th. Piper Sandler decreased their target price on Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Wolfe Research lowered Tempus AI from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Finally, Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Tempus AI currently has an average rating of “Moderate Buy” and an average target price of $61.18.

Hedge Funds Weigh In On Tempus AI

Large investors have recently modified their holdings of the company. Kovitz Investment Group Partners LLC purchased a new stake in Tempus AI in the 3rd quarter worth approximately $1,367,000. China Universal Asset Management Co. Ltd. bought a new position in shares of Tempus AI in the fourth quarter worth $1,091,000. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Tempus AI by 1,591.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after buying an additional 1,145,698 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in Tempus AI during the fourth quarter valued at $178,000. Finally, Captrust Financial Advisors purchased a new position in Tempus AI during the third quarter worth about $2,726,000. 24.22% of the stock is currently owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.